XASEAXIL
Market cap460mUSD
Dec 23, Last price
3.93USD
1D
-1.49%
1Q
-16.72%
IPO
-69.76%
Name
Reviv3 Procare Co
Chart & Performance
P/E
229.74
P/S
16.74
EPS
0.02
Div Yield, %
0.00%
Shrs. gr., 5y
51.20%
Rev. gr., 5y
94.31%
Revenues
27m
+16.91%
Net income
2m
+9.79%
CFO
3k
-99.91%
Earnings
Jan 02, 2025
Profile
Reviv3 Procare Company manufactures, markets, distributes, and sells hair and skin care products in the United States, Canada, Europe, and Asia. It offers PREP shampoos; PRIME hair conditioners; TREAT maintenance care products; BOOST to deliver nutrients and enhance circulation to the scalp; MEND deep hair repair masks for added moisture; and PROTECT, a heat protectant product to prevent damage from irons and dryers, as well as thickening sprays for giving hair more volume and body. The company also provides baby care products, such as shampoos, body washes, and lotions under the LANU brand name; and perfumes, mouthwashes, and deodorants, as well as shaving, makeup, and nail products. It serves business-to-business salon through its network of domestic and international distributors; and individuals through its ecommerce site and various third-party online platforms. Reviv3 Procare Company was incorporated in 2015 and is based in El Monte, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | 2016‑05 | |
| Income | |||||||||
Revenues | 27,499 16.91% | 23,521 906.78% | 2,336 43.01% | ||||||
Cost of revenue | 25,995 | 22,885 | 2,563 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 1,503 | 636 | (227) | ||||||
NOPBT Margin | 5.47% | 2.71% | |||||||
Operating Taxes | (220) | 231 | 2 | ||||||
Tax Rate | 36.29% | ||||||||
NOPAT | 1,724 | 405 | (227) | ||||||
Net income | 2,003 9.79% | 1,825 -1,097.56% | (183) -38.57% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (1,246) | 448 | |||||||
BB yield | 0.89% | ||||||||
| Debt | |||||||||
Debt current | 183 | 241 | 210 | ||||||
Long-term debt | 37 | 139 | 4 | ||||||
Deferred revenue | 481 | 606 | |||||||
Other long-term liabilities | 606 | ||||||||
Net debt | (3,034) | (4,452) | (160) | ||||||
| Cash flow | |||||||||
Cash from operating activities | 3 | 2,918 | (126) | ||||||
CAPEX | (66) | ||||||||
Cash from investing activities | (161) | 1,001 | |||||||
Cash from financing activities | (1,421) | 540 | 3 | ||||||
FCF | (655) | 221 | (136) | ||||||
| Balance | |||||||||
Cash | 3,254 | 4,833 | 374 | ||||||
Long term investments | |||||||||
Excess cash | 1,879 | 3,657 | 257 | ||||||
Stockholders' equity | (129) | (3,442) | (5,287) | ||||||
Invested Capital | 8,489 | 11,373 | 5,684 | ||||||
ROIC | 17.36% | 4.75% | |||||||
ROCE | 17.98% | 8.69% | |||||||
| EV | |||||||||
Common stock shares outstanding | 16,168 | 17,869 | 2,097 | ||||||
Price | 8.68 | ||||||||
Market cap | 140,259 | ||||||||
EV | 137,229 | ||||||||
EBITDA | 1,634 | 732 | (220) | ||||||
EV/EBITDA | 83.98 | ||||||||
Interest | 4 | 3 | 7 | ||||||
Interest/NOPBT | 0.29% | 0.40% | |||||||